跳转至内容
Merck
CN

160415

Sigma-Aldrich

3-(2-吡啶基)-5,6-二苯基-1,2,4-三嗪

≥99%

别名:

5,6-二苯基-3-(2-吡啶基)-1,2,4-三嗪, PDT

登录查看公司和协议定价


About This Item

经验公式(希尔记法):
C20H14N4
CAS号:
分子量:
310.35
Beilstein:
542151
EC 号:
MDL编号:
UNSPSC代码:
12352100
PubChem化学物质编号:
NACRES:
NA.22

质量水平

检测方案

≥99%

mp

191-193 °C (lit.)

SMILES字符串

c1ccc(cc1)-c2nnc(nc2-c3ccccc3)-c4ccccn4

InChI

1S/C20H14N4/c1-3-9-15(10-4-1)18-19(16-11-5-2-6-12-16)23-24-20(22-18)17-13-7-8-14-21-17/h1-14H

InChI key

OTMYLOBWDNFTLO-UHFFFAOYSA-N

正在寻找类似产品? 访问 产品对比指南

一般描述

3-(2-吡啶基)-5,6-二苯基-1,2,4-三嗪(PDT)与高氯酸铜(II)在乙醇中反应,可生成[Cu(PDT)2(CLO42]。

应用

在分光光度法测定酸和酸性溶液中的铁的过程中,使用3-(2-吡啶基)-5,6-二苯基-1,2,4-三嗪作为显色提取试剂。 它也被用作HPLC方法中的柱前衍生试剂,从而通过UV吸光度对Fe(II)进行测定。

象形图

Exclamation mark

警示用语:

Warning

危险分类

Acute Tox. 4 Oral - Eye Irrit. 2 - Skin Irrit. 2 - STOT SE 3

靶器官

Respiratory system

WGK

WGK 3

闪点(°F)

Not applicable

闪点(°C)

Not applicable

个人防护装备

dust mask type N95 (US), Eyeshields, Faceshields, Gloves


分析证书(COA)

输入产品批号来搜索 分析证书(COA) 。批号可以在产品标签上"批“ (Lot或Batch)字后找到。

已有该产品?

在文件库中查找您最近购买产品的文档。

访问文档库

M A Sirotkina et al.
Scientific reports, 9(1), 6492-6492 (2019-04-26)
Prediction of tumour treatment response may play a crucial role in therapy selection and optimization of its delivery parameters. Here we use optical coherence angiography (OCA) as a minimally-invasive, label-free, real-time bioimaging method to visualize normal and pathological perfused vessels
Yvonne H W Derks et al.
Theranostics, 11(4), 1527-1541 (2021-01-08)
Incomplete resection of prostate cancer (PCa) occurs in 15%-50% of PCa patients. Disease recurrence negatively impacts oncological outcome. The use of radio-, fluorescent-, or photosensitizer-labeled ligands to target the prostate-specific membrane antigen (PSMA) has become a well-established method for the
Sungsoon Hwang et al.
Retina (Philadelphia, Pa.), 39(6), 1117-1124 (2018-03-09)
To report the clinical outcomes of reduced-fluence photodynamic therapy (PDT) for symptomatic subfoveal retinal pigment epithelial detachment (RPED) in central serous chorioretinopathy and identify prognostic factors affecting treatment outcome. This retrospective interventional study included 35 eyes of 35 patients with
Thomas J van Rijssen et al.
PloS one, 13(8), e0202549-e0202549 (2018-08-25)
To assess parameters on optical coherence tomography (OCT), and their correlation with best-corrected visual acuity (BCVA) in patients with non-resolving central serous chorioretinopathy (CSC). For 25 non-resolving CSC patients treated with photodynamic therapy (PDT), the thickness of retinal layers was
Yu-Cherng Channing Chang et al.
Scientific reports, 7(1), 9746-9746 (2017-08-31)
Tumor heterogeneity can be elucidated by mapping subregions of the lesion with differential imaging characteristics, called habitats. Dynamic Contrast Enhanced (DCE-)MRI can depict the tumor microenvironments by identifying areas with variable perfusion and vascular permeability, since individual tumor habitats vary

我们的科学家团队拥有各种研究领域经验,包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.

联系技术服务部门